Abstract
We apply a range of techniques (thermal methods, microscopy, X-ray diffraction, IR spectroscopy) to characterize a drug (atenolol), several excipients (PVP=polyvinylpyrrolidone, MGST=magnesium stearate, Avicel©) and drug-excipients mixtures either as prepared, annealed, and exposed to moisture. We compare the data of the mixtures with those computed from a weighted average of similarly treated pure compounds to find evidence of drug properties modified by the interaction with the excipient. We find that thermal response is by far the most sensitive indicator of interaction while IR is the least sensitive one. Avicel© has essentially no interaction with atenolol, while MGST modifies significantly only the thermal response of the drug in the MGST-rich mixtures. PVP interacts strongly with atenolol, and this interaction appears to be mediated by the substantial amount of hydration water the excipient brings in its mixtures with a water-free drug.
Similar content being viewed by others
References
C. Ahlneck and P. Lundgren, Acta Pharm. Suec., 22 (1985) 305.
P. Crowley and L. Martini, Pharm. Techn. Europe, 13 (2001) 26.
C. Ahlneck and G. Zografi, Int. J. Pharm., 62 (1990) 87.
D. C. Monkhouse, Drug Dev. Ind. Pharm., 10 (1984) 1373.
J. T. Carstensen, Drug Dev. Ind. Pharm., 14 (1988) 1927.
A. T. M. Serajuddin, A. B. Thakur, R. N. Ghoshal, M. G. Fakes, S. A. Ranadive, K. R. Morris and S. A. Varia, J. Pharm. Sci., 88 (1999) 696.
A. A. Van Dooren, Drug Dev. Ind. Pharm., 9 (1983) 43.
D. C. Monkhouse and A. Maderich, Drug Dev. Ind. Pharm., 15 (1989) 2115.
K. J. Hartauer and J. K. Guillory, Drug Dev. Ind. Pharm., 17 (1991) 617.
W. G. Wolfgang and K. T. Biberach, Eur. J. Pharm. Biopharm., 41 (1995) 194.
G. Bruni, L. Amici, V. Berbenni, A. Marini and A. Orlandi, J. Therm. Anal. Cal., 68 (2002) 561.
V. Caplar, Z. Mikotic-Mihun, H. Hofman, J. Kuftinec, F. Kajfez, A. Nagl and N. Blazevic, Analytical profiles of drug substances and excipients, K. Florey, Academic Press 1984, p. 1.
G. Pyramides, J. W. Robinson and S. W. Zito, Pharm. Biom. Anal., 13 (1995) 103.
S. A. Botha and A. P. Lötter, Drug Dev. Ind. Pharm., 16 (1990) 1945.
A. Marini, V. Berbenni, S. Moioli, G. Bruni, P. Cofrancesco, C. Margheritis and M. Villa, J. Therm. Anal. Cal. 73 (2003) 529.
C. A. Oksanen and G. Zografi, Pharm. Res., 7 (1990) 654.
R. Nair, N. Nyamweya, S. Gönen, L. J. Martinez-Miranda and S. W. Hoag, Int. J. Pharm., 225 (2001) 83.
K. Süvegh and R. Zelkó, Macromolecules, 35 (2002) 795.
T. A. Miller and P. York, Int. J. Pharm., 23 (1985) 55.
S. A. Sharpe, M. Celik, A. W. Newman and H. G. Brittain, Struct. Chem., 8 (1997) 2.
K. M. Picker and S. W. Hoagi, J. Pharm. Sci., 91 (2002) 342.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marini, A., Berbenni, V., Pegoretti, M. et al. Drug-excipient compatibility studies by physico-chemical techniques; The case of Atenolol. Journal of Thermal Analysis and Calorimetry 73, 547–561 (2003). https://doi.org/10.1023/A:1025478129417
Issue Date:
DOI: https://doi.org/10.1023/A:1025478129417